Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Cision PR Newswire

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...
Cision PR Newswire

Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List

PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 /PRNewswire/ -- Innovent Biologics, Inc....
Cision PR Newswire

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...
Cision PR Newswire
1...1,7031,7041,705...4,530Page 1,704 of 4,530